BNET Industries

Market Cap:$22.6M
  • Public
  • US
Dow Jones Description

Transdel Pharmaceuticals, Inc. is a specialty pharmaceutical company developing non-invasive, topically-delivered medications. The Company's innovative patented proprietary Transdel cream formulation technology is designed to facilitate the effective penetration of drugs through the tough skin barrier to reach the target underlying tissues. In the case of Ketotransdel , the Transdel cream allows the active ingredient ketoprofen, a non steroidal anti-inflammatory drug, to reach the target soft tissue and exert its well-known anti-inflammatory and analgesic effects. The Company is also investigating other drug candidates and treatments for transdermal delivery using the Transdel platform technology for products in pain management and other therapeutic areas and for cosmetic/cosmeceutical products.

Number of Employees 3
Contact Information

4225 Executive Sq Ste 460

La Jolla, California 92037

transdelpharma....

(858) 457-5300

NAICS Code Gold Ore Mining: 212221

Recent Events

  • Transdel Pharmaceuticals names new chief medical officer

    10/14/09 - Mgmt. Change Entering - Other - View Story

  • Transdel Pharmaceuticals Announces Positive Phase 3 Study Results for Lead Topical Pain Drug Ketotransdel

    10/08/09 - Licensing / Contract - View Story

  • Transdel Pharma - Poised For Gain Or Pain?

    9/28/09 - Financial Announcement - View Story

  • Transdel Pharmaceuticals enters into license agreement with JH Direct

    6/12/09 - Joint Venture / Alliance - View Story

advertisement
     TDLP $1.45 0.00 (0.00% )
Average Volume 17,734
Shares Outstanding 15.65M
Market Cap 22.7M
Year High 4
Year Low 0.55
Earnings Per Share -0.29
P/E Ratio -5.00
Dividend N/A
Yield N/A
advertisement
Click Here